NTx Bio
2 known investors
NTx Bio develops automated, continuous-flow cell-free biomanufacturing systems—including its NTxscribe bioreactors and proprietary enzymes—for on-demand, benchtop production of RNA (mRNA and saRNA) and proteins. It serves researchers and companies producing next-generation therapeutics, aiming to make manufacturing faster, scalable, and lower-cost than traditional batch IVT or outsourced methods.
Investors · 2
In the news
Frequently asked questions
- What does NTx Bio do?
- NTx Bio develops automated, continuous-flow cell-free biomanufacturing systems—including its NTxscribe bioreactors and proprietary enzymes—for on-demand, benchtop production of RNA (mRNA and saRNA) and proteins. It serves researchers and companies producing next-generation therapeutics, aiming to make manufacturing faster, scalable, and lower-cost than traditional batch IVT or outsourced methods.
- Who are NTx Bio's investors?
- NTx Bio's investors include Anzu Partners, BlueStone Venture Partners.